OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind (Madison Mills/Axios)
Techmemeen
Madison Mills / Axios : OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind — OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios.
This is a short summary published by AI Global Wire. The full article is owned and hosted by Techmeme — open it there to read it in full.
Read the full story at Techmeme- OpenAI
- Agenter
Related AI news
- Dell sees company knowledge, not AI models, as its competitive edgeSiliconANGLE · October 20, 2026
- Deepseek open-sources the inference engine that powers its fastest and cheapest AI modelThe Decoder · October 20, 2026
- Dell’s security chief warns AI is lowering the barriers to sophisticated cyberattacksSiliconANGLE · October 20, 2026
- ChatGPT now lets you lock your chatsTechCrunch AI · October 20, 2026
- A US judge dismisses a civil sexual abuse lawsuit brought against Sam Altman by his sister, after she refused to appear for an independent medical examination (Luc Cohen/Reuters)Techmeme · October 20, 2026
- Work management context for AI agents with Smartsheet MCP on AWSAWS Machine Learning · October 20, 2026